The hypertriglyceridemia of infection was traditionally thought to represent the mobilization of substrate to fuel the body's response to the infectious challenge. However, we have previously shown that triglyceride-rich lipoproteins can protect against endotoxin-induced lethality. The current studies examine the mechanism by which this protection occurs. Rats infused with a lethal dose of endotoxin preincubated with chylomicrons had a reduced mortality compared with rats infused with endotoxin alone (15 vs. 76%, P < 0.001). Preincubation with chylomicrons increased the rate of clearance of endotoxin from plasma and doubled the amount of endotoxin cleared by the liver (30 +/-1 vs. 14 +/-2% of the total infused radiolabel, P < 0.001). In addition, autoradiographic studies showed that chylomicrons directed more of the endotoxin to hepatocytes and away from hepatic macrophages. Rats infused with endotoxin plus chylomicrons also showed reduced peak serum levels of tumor necrosis factor as compared with controls (14.2 +/-3.3 vs. 44.9 +/-9.5 ng/ml, mean +/-SEM, P = 0.014). In separate experiments, chylomicrons (1,000 mg triglyceride/kg) or saline were infused 10 min before the infusion of endotoxin. Chylomicron pretreatment resulted in a reduced mortality compared with rats infused with endotoxin alone (22 vs. 78%, P < 0.005). Therefore, chylomicrons can protect against endotoxininduced lethality with and without preincubation with endotoxin. The mechanism by which chylomicrons […] 
ously shown that triglyceride-rich lipoproteins can protect against endotoxin-induced lethality. The current studies examine the mechanism by which this protection occurs. Rats infused with a lethal dose of endotoxin preincubated with chylomicrons had a reduced mortality compared with rats infused with endotoxin alone (15 vs. 76%, P < 0.001). Preincubation with chylomicrons increased the rate of clearance of endotoxin from plasma and doubled the amount of endotoxin cleared by the liver (30±1 vs. 14±2% of the total infused radiolabel, P < 0.001). In addition, autoradiographic studies showed that chylomicrons directed more of the endotoxin to hepatocytes and away from hepatic macrophages. Rats infused with endotoxin plus chylomicrons also showed reduced peak serum levels of tumor necrosis factor as compared with controls (14.2±3.3 vs. 44 .9±9.5 ng/ml, mean±SEM, P = 0.014). In separate experiments, chylomicrons (1,000 mg triglyceride/kg) or saline were infused 10 min before the infusion of endotoxin. Chylomicron pretreatment resulted in a reduced mortality compared with rats infused with endotoxin alone (22 vs. 78%, P < 0.005). Therefore, chylomicrons can protect against endotoxin-induced lethality with and without preincubation with endotoxin. The mechanism by which chylomicrons protect against endotoxin appears to involve the shunting of endotoxin to hepatocytes and away from macrophages, thereby decreasing macrophage activation and the secretion of cytokines. (J. Clin. Invest. 1993 . 91:1028-1034.) Key words: lipoproteins * triglycerides * lipopolysaccharide * cytokines * liver mediate the acute phase response, a change in the hepatic synthetic program with increased production of acute phase proteins that aid host defense (4) (5) (6) (7) . The host response to infection also includes cytokine-mediated changes in intermediary metabolism such as hypertriglyceridemia (8, 9) , which is due to both increases in hepatic triglyceride-rich lipoprotein synthesis (10, 11 ) and decreases in lipoprotein lipase-mediated lipoprotein clearance ( 12, 13) .
The increased production of triglyceride-rich lipoproteins by the liver is now postulated to be a part of the acute phase response, as lipoproteins serve not only as a potential source of metabolic fuel ( 14) but also as direct participants in the protective process. All lipoproteins, including cholesterol-rich HDL (15) (16) (17) (18) (19) (20) and LDL (18) (19) (20) and triglyceride-rich VLDL and chylomicrons ( 19, 20) , have been shown to bind endotoxin, subsequently reducing its toxic properties. Recent data from our laboratory has demonstrated a dose-dependent increase in mouse survival when varying concentrations of either VLDL or chylomicrons were incubated with a lethal dose of Escherichia coli endotoxin before its intraperitoneal injection (20) . In addition, we found that in normal humans triglyceride-rich lipoproteins contained detectable levels of endogenous endotoxin that was presumably scavenged in vivo (20) .
The purpose of this study was to examine the mechanism by which triglyceride-rich lipoproteins afford protection from endotoxemia. In these experiments we measured survival, and the clearance, hepatic uptake, tissue distribution of endotoxin, and serum levels of TNF in rats infused with a lethal dose of endotoxin that had been incubated with either nascent rat chylomicrons or normal saline. We also examined whether protection from endotoxic shock could be afforded by infusion of chylomicrons in vivo before administration of endotoxin.
Introduction
The host responds to bacterial, viral, fungal, and parasitic infection with the secretion of cytokines, which mediate the host's immunologic response by recruiting cells and activating a variety of cellular functions (1) (2) (3) . In addition, cytokines Depyrogenation. To avoid contamination with exogenously derived endotoxin, all heat-stable materials used in the isolation, processing, and assay of solutions to be injected into the rats were rendered sterile and free of detectable endotoxin ( < 5-10 pg/ml) by previously reported methods (20 (20) , were taken to avoid the introduction of exogenous endotoxin during the collection process. To collect mesenteric lymph, rats received a gavage feeding of 3-4 ml of a 1:3 (vol/vol) corn oil to nonfat dry milk mixture. Approximately 1 h after the feeding a right flank incision was performed under sodium pentobarbital anesthesia (25-40 mg/kg i.p.), the lipemic mesenteric lymph duct identified, and cannulated with PE 50 polyethylene tubing under 2X magnification. The tubing was secured in place with liquid glue, the flank incision closed, and the animal recovered in a restriction cage. Lymph production was promoted by the subcutaneous injection of sterile saline (20 cc/kg) and the lymph was collected into sterile, endotoxin-free flasks in an ice bath for 4 to 6 h, after which the animals were killed. The mesenteric lymph was stored at 40C and used within 72 h ofits collection. The lymph preparations contained no demonstrable apoprotein B-100 (VLDL) by Coomassie staining ofgels after polyacrylamide gel electrophoresis (data not shown). The triglyceride content of the mesenteric lymph was determined using a standard enzymatic assay (Sigma Chemical Co. In a second experimental protocol, male Sprague-Dawley rats (180-225 g) were infused with either chylomicrons ( 1,000 mg triglyceride/kg) or an equivalent volume of saline followed by a separate injection of a lethal dose of E. coli (055:B5) endotoxin via an ileofemoral venous catheter -10 min later. As described above, an intravenous dose of D-galactosamine was administered and the rat mortality rate was determined at 48 h.
Plasma clearance of endotoxin-chylomicron complexes. Male Sprague-Dawley rats (314±21 g) were infused with a lethal dose of E. coli (055:B5) '251I-labeled endotoxin, 14 ,g/kg, sp act = 1.96 uCi/,ug, via an ileofemoral venous catheter. The endotoxin was incubated with either rat mesenteric lymph containing nascent chylomicrons, (endotoxin plus chylomicrons, 500 mg chylomicron triglyceride/kg) or an equal volume of normal saline (endotoxin alone) as previously described. D-Galactosamine (375 mg/kg) was given intravenously just before the endotoxin infusion. Serial blood samples were obtained via rat tail vein and assayed for 1251 by gamma counting.
Plasma clearance ofchylomicron triglyceride. Male Sprague-Dawley rats (250-280 g) received an intravenous infusion of nascent chylomicrons, either 500 or 1,000 mg chylomicron triglyceride/kg. Serial blood samples were obtained from an ileofemoral venous catheter. Plasma triglyceride levels were determined using a standard enzymatic assay (Sigma Chemical Co. 
Results
Effect ofpreincubating chylomicrons with endotoxin on endotoxin-induced death. Control animals receiving endotoxin plus saline experienced a 76% mortality rate at 48 h as compared with a 15% mortality rate for rats receiving endotoxin plus chylomicrons (Table I, P < 0.001). Most of the control animals appeared ill within 4 h ofthe endotoxin injection and died within 36 h. In contrast, the rats that received preincubated chylomicron-endotoxin complexes frequently appeared ill during the early hours of the study but were generally fully recovered by the end of the observation period.
Effect ofpretreating rats with chylomicrons on endotoxininduced death. Chylomicrons did not have to be incubated with endotoxin before injection to be protective; however, to achieve the same degree of protection observed with preincubation, the quantity ofchylomicron triglyceride infused had to be doubled (I g chylomicron triglyceride/kg). Rats pretreated with saline followed by endotoxin experienced a 78% mortality rate at 48 h as compared with a 22% mortality rate for rats pretreated with chylomicrons (14/18 vs. 4/18, P < 0.005) (Fig. 1) . Thus, circulating triglyceride-rich lipoproteins can protect rats against exogenously administered endotoxin.
Effect ofchylomicrons on theplasma clearance of'25I-endotoxin. To examine the clearance of endotoxin in our rodent model, two groups of rats received endotoxin infusions preincubated with chylomicrons or saline in a manner identical to the mortality experiments reported above except these infusions contained '251I-labeled endotoxin. Endotoxin plus chylomicrons were cleared more rapidly from the circulation than endotoxin plus saline, with both showing a biphasic clearance pattern (Fig. 2) .
Plasma clearance ofchylomicron triglyceride. The infusion of 500 mg chylomicron triglyceride/kg produced a plasma triglyceride concentration of 883±74 mg/dl 5 min after infusion. Plasma triglyceride was rapidly cleared, falling to 148±13 mg/ dl 1 h after infusion. Similarly, the infusion of 1,000 mg chylomicron triglyceride/kg produced an early rise in plasma triglyceride concentration (4,700±624 mg/dl 5 min after chylomicron infusion, which wasjust before endotoxin administration). Again, plasma triglyceride was rapidly cleared, falling to 1,067±296 mg/dl I h after infusion, and to 1 15±46 mg/dl 2 h after infusion. (Data expressed as the mean of four animals±SEM in each group.) Effect ofchylomicrons on the tissue distribution of'25I-endotoxin. Rats were infused with 1251-endotoxin plus either chylomicrons or saline and killed 45 min after the endotoxin infusion. Of the various tissues that were harvested and assayed, liver, blood, and skeletal muscle revealed significant differences in the content of radiolabel in animals that received labeled endotoxin plus chylomicrons versus those animals that received labeled endotoxin alone (Fig. 3 A) . The 1251 content of livers from rats that received endotoxin plus chylomicrons were increased twofold over that of livers from saline-treated Rats were infused with a lethal dose of E. coli '25I-labeled endotoxin. When the identical experiment was conducted without administration of D-galactosamine, a similar distribution pattern of '251-endotoxin into liver and blood was observed (Fig. 3 B) . The 1251 content of livers from rats that received endotoxin plus chylomicrons was increased twofold over that of livers from saline-treated rats (43±1 vs. 19±8% oftotal infused radiolabel, respectively, P < 0.03). Conversely, the contents of radiolabel in blood from rats treated with endotoxin plus chylomicrons was decreased by 80% as compared with rats treated with endotoxin alone (5±1 vs. 31±5% of total infused radiolabel, P < 0.003).
Effect of chylomicrons on the intrahepatic localization of I251-endotoxin. Hepatic autoradiographs were obtained 45 min after rats were infused with '251-endotoxin plus either saline or chylomicrons. After endotoxin plus saline was infused, the majority of the radiolabel in the liver was clustered over perisinusoidal cells resembling Kupffer cells, rarely over hepatocytes (Fig. 4 A) . These results are consistent with those from other laboratories, suggesting that endotoxin is normally cleared by the reticuloendothelial system, especially by Kupffer cells (25) (26) (27) (28) (29) . However, after the infusion of endotoxin plus chylomicrons there was both a striking increase in radiolabel overlying hepatocytes and a relative decrease in the density of the label clustered over Kupffer cells (Fig. 4 B) .
Light microscopic examination ofthe 3-,um-thick sections stained with hematoxylin and eosin alone revealed no evidence of significant hepatocellular damage in both controls and chylomicron-treated animals.
Effect ofchylomicrons on endotoxin-induced TNFproduction. Hepatocytes, unlike macrophages, are not known to produce TNF or other cytokines when exposed to endotoxin and thus the shunting of endotoxin toward hepatocytes and away from macrophages could presumably result in reduced cyto- Rats were infused with a lethal dose of E. coli '25I-labeled endotoxin.
The endotoxin was incubated with either rat mesenteric lymph containing nascent chylomicrons (endotoxin plus chylomicrons) or an equal volume of normal saline (endotoxin alone). 45 min after the endotoxin infusion the rats were killed. Each animal's liver, spleen, heart, adipose tissue, skeletal muscle, and blood were harvested and assayed for 125I by gamma counting. The data are the mean±SEM obtained from five animals. *, t significantly different from control, * P < 0.001, tP < 0.009. (A) Animals received -galactosamine just before endotoxin infusion; (B) -galactosamine withheld.
kine elaboration. Since cytokines mediate the lethal effects of endotoxemia (30) (31) (32) , a reduction in circulating cytokine levels would result in reduced endotoxin lethality. The peak serum concentration of TNF was measured to determine whether chylomicrons reduce the circulating level of endotoxin-induced cytokines in our animal model. Rats receiving endotoxin plus chylomicrons had a 68% reduction in serum TNF levels 90 min after infusion as compared with rats receiving endotoxin alone (14.2±3.3 vs. 44 .9±9.5 ng/ml, respectively, mean±SEM, P = 0.014, Table I ). When one compares the serum TNF levels in all of the rats that survived versus all of those that died from both groups, regardless of whether they received chylomicrons or saline, there is a significant difference in TNF levels (survived 15 .2±4.1 vs. died 44.1±9.6 ng/ml, P = 0.02). This difference further highlights the role of TNF in mediating the toxicity of endotoxin.
Discussion
We hypothesized that chylomicrons may protect against endotoxin-induced lethality by altering endotoxin's metabolism. These data show that intravenous administration of endotoxin after preincubation with chylomicrons (a) protects against endotoxin-induced death in rats; (b) increases the clearance rate of endotoxin from plasma; (c) alters endotoxin's tissue distribution; (d) increases the hepatocellular uptake of endotoxin, while shunting endotoxin away from Kupffer cells; and (e) reduces peak serum levels of TNF, a macrophage/Kupffer cell product. Hence, triglyceride-rich lipoproteins can redirect the metabolism of endotoxin, thereby affording protection against this toxic macromolecule. In addition, we have shown that preincubation of chylomicrons with endotoxin is not necessary to achieve the protective effect, although preincubation does reduce the quantity of chylomicron triglyceride required for this protection.
Previous studies examining endotoxin metabolism have demonstrated that the reticuloendothelial system is primarily responsible for the clearance of endotoxin from the circulation (25, 26) . In particular, hepatic macrophages (Kupffer cells) appear to be the predominant cell type involved in the clearance process (27) (28) (29) (30) (35) (36) (37) and in vivo (20) . In addition, there is evidence that human VLDL may bind endogenous endotoxin in vivo (20) . Specifically, VLDL harvested from healthy normolipidemic volunteers frequently revealed detectable levels ofendotoxin. The cholesterol ester-rich LDL and HDL also have been shown to decrease endotoxin-induced toxicity in rodents ( 15, 18, 20, 38) . The complexing ofendotoxin to these cholesterol ester-rich lipoproteins may also redirect their fate (39) . As demonstrated here, when chylomicrons increase the amount of endotoxin delivered to the hepatocyte, there is a concomitant decrease in plasma TNF levels, a cytokine that is a known mediator of endotoxic shock (30, 31 ) . It is possible that the levels of other cytokines involved in shock, such as IL-1 (32), may also be decreased. The binding of endotoxin to lipoproteins in vitro prevents endotoxin-induced activation of monocyte/macrophages and secretion of TNF, IL-1, and IL-6 (40, 41 ) . The apparent increase in endotoxin delivered to hepatocytes could result in some degree of cellular toxicity. We did not observe such hepatocellular toxicity at the 45-min time point. However, this remains an important theoretical concern as it could limit the repeated administration ofchylomicrons in a sepsis model, where there is ongoing release of endotoxin. D-Galactosamine toxicity also may be a confounding factor in this model, possibly altering the ability of hepatocytes to eliminate endotoxin via bile (42) .
The interaction between lipoproteins and endotoxin may represent another nonlipid transport, antiinfectious function for lipoproteins. Lipoproteins have been found to be potent inhibitors of the infectivity of the murine xenotropic type C virus (43), Japanese encephalitis (44), Epstein-Barr virus (45) , rabies virus, and vesicular stomatitis virus (46) . Apolipoprotein A-I, the predominant apoprotein found in HDL, has recently been shown to prevent fusion of the human immunodeficiency virus with cells (47) . HDL also have powerful antiparasitic activity as they can effectively lyse and kill Trypanosoma brucei (48) (49) (50) . Lipoproteins also decrease the inflammatory response to monosodium urate crystals ( 51 ). Thus, lipoproteins can decrease the toxicity of a variety of harmful biological and chemical agents.
Recently, an increasing roster ofcytokines that are induced by a variety of infectious and inflammatory conditions have been shown to mediate changes in lipid metabolism (9) . TNF (9, (52) (53) (54) , the interferons (9, 52, 54, 55) , IL-1 (9, (55) (56) (57) , and IL-6 (58) are among those that can increase hepatic fatty acid and lipoprotein synthesis or decrease lipoprotein lipase and lipid storage by adipocytes. These processes would increase plasma concentrations of triglyceride-rich lipoproteins or at least maintain their level despite infection (cytokine)-induced anorexia. Our data and that of others suggest that the triglyceride-rich lipoproteins may play a central role in the clearance and neutralization of endotoxin and viruses. The multiple humoral stimuli that converge on this system to maintain lipoprotein levels during infection attest to its critical function in host defense.
